Advertisement

Cancer Living with Cancer


The number of cells containing the genetic defect in some leukemias can be reduced


Today, highly sensitive tests can identify the presence of the gene responsible for chronic myeloid leukemia (CML). Just one cancerous cell can be detected among hundreds of thousands of cells. The faulty gene, found on the Philadelphia chromosome, creates an enzyme that interferes with the regulation of white blood cell production. The result is an explosion in the growth of white blood cells, the hallmark of CML. A novel medication tackles the disease by reducing the number of white blood cells and the number of cells containing the faulty gene.


Advertisement



Site Search:

Can't find what you're looking for? Try our quick search:

Write a letter to the editor | Subscribe to the Tribune | Place an Ad Online

Site Tools

RSS Feeds:
XML
All feeds/RSS FAQ

Most popular:

This feature requires the Macromedia Flash Plugin. Please visit http://www.macromedia.com/go/getflashplayer to download this plugin.


Advertise With Us:
Online | In Print | Broadcast